Attached files
file | filename |
---|---|
8-K - FORM 8-K - NxStage Medical, Inc. | b83849e8vk.htm |
EXHIBIT 99.1
NxStage Names Joseph Turk President, North America
LAWRENCE, MA, December 20, 2010NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer
of innovative dialysis products, today announced that Joseph E. Turk, Jr., has been promoted to the
position of President of its North American operations. Reporting to Jeffrey Burbank, Chief
Executive Officer of NxStage, Mr. Turk will continue to manage the Companys North American
commercial teams across the Companys three markets (Home, Critical Care, and In-Center) and will
be responsible for driving NxStages worldwide product portfolio.
Joe has been a driving force behind the Companys ability to successfully execute against its
strategic initiatives and achieve its goals, said Jeffrey Burbank, Chief Executive Officer of
NxStage. As the scale of our business increases, Joes exceptional track record as a
multi-faceted operating executive will be a great asset to our growth initiatives across all three
of our markets.
Mr. Turk, age 43, joined NxStage Medical in 2000 as Vice President of Marketing. He served as Vice
President of Sales and Marketing from 2002 to 2006, and most recently served as Senior Vice
President of Commercial Operations since 2006.
NxStage is a great company with a tremendous future and growth opportunities across all its
markets, and I feel privileged to have worked with such a talented team in achieving our milestones
to date, said Mr. Turk. I am proud of this recognition and I look forward to continuing to
deliver value to our patients, customers, partners, and all of our stakeholders.
Before joining NxStage, Mr. Turk served as Director of New Business Development at Boston
Scientific. Prior to this, he was one of the leaders of McKinsey & Companys Midwest Health Care
and Biotechnology Practice as a Senior Engagement Manager in the firms Chicago Office.
Mr.Turk received his AB in Economics from Wabash College and an MBA in Marketing, Finance and
Operations from Northwestern Universitys J.L. Kellogg School.
About NxStage Medical, Inc.
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment
of End Stage Renal Disease (ESRD) and acute kidney failure. For more information on NxStage and its
products, please visit NxStages website at www.nxstage.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words anticipate, believe, expect,
estimate, plan, and similar expressions are generally intended to identify forward-looking
statements. Actual results may differ materially from those indicated by these forward-looking
statements as a result of various important factors that are discussed in NxStages Quarterly
Report on Form 10-Q for the period ended September 30, 2010 filed with the SEC. NxStage is under no
obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking
statements, whether as a result of new information, future events or otherwise.
# # #